-+ 0.00%
-+ 0.00%
-+ 0.00%
Fulcrum Therapeutics 10% owner Kevin Tang reports buying $892,170 of common shares
Share
Listen to the news
Fulcrum Therapeutics 10% owner Kevin Tang reports buying $892,170 of common shares
  • Tang Capital’s Kevin Tang, a 10% owner, disclosed open-market purchases of 250,000 Fulcrum Therapeutics common shares.
  • Holdings rose to 6,913,329 shares through Tang-managed entities.
  • Purchases were priced around USD 3.54 to USD 3.58 per share.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fulcrum Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178579-26-000014), on July 15, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending